r-Hu-EPO (recombinant human erythropoietin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for r-Hu-EPO (recombinant human erythropoietin), covering 2006-09-11 to 2006-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course [Phase 3]